Search
Close this search box.
Trending now:  
Cardiac Shockwave Therapy: A Promising Treatment for Ischemic Heart Failure
The Evolution of Cardiovascular Magnetic Resonance: A 50-Year Journey
Vessel-Level Coronary Atherosclerotic Plaque Activity Predicts Myocardial Infarction Risk
DanGer Shock: Microaxial Flow Pump versus Standard Care in Infarct-Related Cardiogenic Shock
EuroPCR 2024 Highlights

Content for healthcare professionals only

Podcast |

04 Jun 2024
impella
impella
Cardiology Update
Loading
/

The DanGer Shock trial assessed the efficacy of the Impella CP ventricular assist device in reducing mortality following myocardial infarction (MI). In this episode, Dr. Chadi Alraies discusses this important trial with the principal investigator, Professor Jacob Møller.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram.

Share:

Related Topics